Table 2.
Unmet needs | Future directions |
---|---|
Novel medications with CMR benefits |
• Identification of druggable CMR connectors • Further efficacy and safety data of novel therapies |
Combination therapy strategy |
• Better understanding of drug mechanisms of action • Outcomes trials testing combination therapies |
Integrated management of CMR disease | • Multidisciplinary approach |
Risk-stratified personalized care |
• Risk score validation for individualized prognostication • Clinical trials in specific populations (women/young/primary prevention) |
Drug prioritization | • Head-to-head drug comparative trials |
CMR, cardio-metabolic-renal